Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学skin cancer

Brigitte Dreno

布里吉特·德雷诺

MD, PhD

🏢University Hospital of Nantes, Nantes University(南特大学医院,南特大学)🌐France

Professor of Dermatology; Head, Dermatology Department and Cancer Skin Center皮肤科教授;皮肤科和皮肤癌中心主任

62
h-index
2
Key Papers
3
Awards
2
Key Contributions

👥Biography 个人简介

Brigitte Dreno is Professor and Head of Dermatology at the University Hospital of Nantes and a pre-eminent French skin oncology researcher. She has led the European EADO (European Association of Dermato-Oncology) as past president and contributed to European guidelines for rare skin malignancies including dermatofibrosarcoma protuberans and sebaceous carcinoma. Her work on DFSP characterised the COL1A1-PDGFB fusion gene biology and established imatinib as the standard systemic therapy for unresectable or recurrent disease. She also investigates the microbiome-immune axis in skin carcinogenesis.

Share:

🧪Research Fields 研究领域

Dermatofibrosarcoma Protuberans隆突性皮肤纤维肉瘤
Imatinib DFSP伊马替尼治疗DFSP
Rare Mesenchymal Skin Tumours罕见间叶性皮肤肿瘤
Sebaceous Carcinoma皮脂腺癌
Adnexal Skin Tumour Pathology皮肤附属器肿瘤病理学

🎓Key Contributions 主要贡献

Imatinib for Dermatofibrosarcoma Protuberans

Contributed to European clinical data establishing imatinib (gleevec) as effective neoadjuvant and palliative systemic therapy for DFSP harbouring COL1A1-PDGFB gene fusion, enabling surgery for previously inoperable tumours.

European Guidelines for Rare Skin Cancers

Led EADO expert panels developing consensus guidelines for management of dermatofibrosarcoma protuberans, sebaceous carcinoma, Merkel cell carcinoma, and other rare adnexal malignancies, standardising care across European oncology centres.

Representative Works 代表性著作

[1]

Dermatofibrosarcoma protuberans: European guidelines for diagnosis and treatment

European Journal of Cancer (2022)

EADO consensus guidelines covering pathological diagnosis with COL1A1-PDGFB FISH, surgical margin requirements, imatinib indications, and follow-up protocols for DFSP.

[2]

Sebaceous carcinoma of the skin: diagnostic criteria, molecular landscape, and emerging systemic therapies

JAMA Dermatology (2023)

Comprehensive review of sebaceous carcinoma immunohistochemistry, mismatch repair deficiency frequency, microsatellite instability, and rationale for pembrolizumab in MMR-deficient cases.

🏆Awards & Recognition 奖项与荣誉

🏆European Academy of Dermatology and Venereology Presidential Award
🏆EADO Lifetime Achievement in Dermato-Oncology Award
🏆French Society of Dermatology Grand Prix de Recherche

📄Data Sources 数据来源

Last updated: 2026-01-15 | All information from publicly available academic sources

关注 布里吉特·德雷诺 的研究动态

Follow Brigitte Dreno's research updates

留下邮箱,当我们发布与 Brigitte Dreno(University Hospital of Nantes, Nantes University)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment